Metformin Plus Irinotecan for Refractory Colorectal Cancer

NCT01930864 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms
Adenocarcinoma

Interventions

DRUG: metformin
DRUG: irinotecan

Sponsor

Barretos Cancer Hospital

Collaborators

[object Object]
[object Object]